HALOPERIDOL DEC 500 MG/5 ML VL
For 5 mL
Pharmacies pay
$77.99 filed
5 × $15.59807 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part B pays
$48.47 derived
5 × $9.694 per ML, Part B limit
Medicare's price is not your price.
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
The spread
0.62× estimated
Medicare pays 38% less than pharmacies pay.
14 labelers share HCPCS J1631 on the CMS crosswalk, so its payment limit is an average across all their products billed under that code, not this NDC’s own price.
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Cost-plus estimate
$94.69 estimated
$77.99 + $11.70 (15%) + $5.00 fee per fill = $94.69
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
HALOPERIDOL DEC 500 MG/5 ML VL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as haloperidol decanoate.
FDA gives its dosage form as “injection” and “injection, solution” and its route as intramuscular.
FDA lists 10 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Sagent Pharmaceuticals and Fresenius Kabi USA, LLC.
FDA’s Established Pharmacologic Class for it is Typical Antipsychotic.
The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $77.99 for 5 mL (5 × $15.59807 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
The 10 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Somerset Therapeutics, LLC | 2 | $15.59807 per ML filed |
| Armas Pharmaceuticals Inc. | 1 | $15.59807 per ML filed |
| BluePoint Laboratories | 1 | $15.59807 per ML filed |
| Caplin Steriles Limited | 1 | $15.59807 per ML filed |
| Fresenius Kabi USA, LLC | 1 | $15.59807 per ML filed |
| Hikma Pharmaceuticals USA Inc. | 1 | $15.59807 per ML filed |
| Lifestar Pharma LLC | 1 | $15.59807 per ML filed |
| Meitheal Pharmaceuticals Inc. | 1 | $15.59807 per ML filed |
| Sagent Pharmaceuticals | 1 | $15.59807 per ML filed |
| Zydus Pharmaceuticals USA Inc. | 1 | $15.59807 per ML filed |
All 11 NDCs, with labeler and price
- 00143-9296-01 · Hikma Pharmaceuticals USA Inc. · $15.59807 per ML · eff. 2026-09-23 filed
- 25021-0834-05 · Sagent Pharmaceuticals · $15.59807 per ML · eff. 2026-09-23 filed
- 63323-0471-05 · Fresenius Kabi USA, LLC · $15.59807 per ML · eff. 2026-09-23 filed
- 65145-0169-01 · Caplin Steriles Limited · $15.59807 per ML · eff. 2026-09-23 filed
- 68001-0659-41 · BluePoint Laboratories · $15.59807 per ML · eff. 2026-09-23 filed
- 70069-0384-01 · Somerset Therapeutics, LLC · $15.59807 per ML · eff. 2026-09-23 filed
- 70069-0868-01 · Somerset Therapeutics, LLC · $15.59807 per ML · eff. 2026-09-23 filed
- 70710-1464-01 · Zydus Pharmaceuticals USA Inc. · $15.59807 per ML · eff. 2026-09-23 filed
- 70756-0625-85 · Lifestar Pharma LLC · $15.59807 per ML · eff. 2026-09-23 filed
- 71288-0504-05 · Meitheal Pharmaceuticals Inc. · $15.59807 per ML · eff. 2026-09-23 filed
- 72485-0522-01 · Armas Pharmaceuticals Inc. · $15.59807 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
4 other products in the NADAC file share the FDA nonproprietary name haloperidol decanoate with HALOPERIDOL DEC 500 MG/5 ML VL.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| HALOPERIDOL DEC 50 MG/ML AMPUL | $20.75247 per ML filed | $4.847 per ML derived |
| HALOPERIDOL DEC 50 MG/ML VIAL | $6.57233 to $12.67801 per ML filed | $4.847 per ML derived |
| HALOPERIDOL DEC 100 MG/ML AMP | $33.92227 per ML filed | $9.694 per ML derived |
| HALOPERIDOL DEC 100 MG/ML VIAL | $7.5241 to $16.1395 per ML filed | $9.694 per ML derived |
| HALOPERIDOL DEC 500 MG/5 ML VL this page | $15.59807 per ML filed | $9.694 per ML derived |
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Compared with its class
The middle of its 11 NDCs’ NADAC prices is $15.59807 per ML filed.
Of the 6 other products in FDA’s Typical Antipsychotic class priced per ML, 3 have a higher middle NADAC price and 3 a lower one. The one in the middle is HALOPERIDOL DEC 50 MG/ML VIAL, at $12.05213 per ML filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part B’s payment limit for HCPCS J1631, for 2026-10-01 to 2026-12-31, comes to $48.47 for 5 mL, or $9.694 per ML once converted to NADAC’s unit for this product.
Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.
The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.9694 per 50 MG.
9 of the product’s 11 NDCs have this Medicare figure; the other 2 do not, and the interactive card says why for each.
Medicare's price is not your price.
What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 5 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 5 mL; your package may hold a different amount.
- If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 5 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 5 mL in one package for all 11 NDCs of this product (“1 VIAL in 1 BOX (0143-9296-01) / 5 mL in 1 VIAL”), so the card starts at one package: 5 ML. Change it to match your prescription.